Trial Information

Summary: Elbow Pain

The primary objective of this study is to demonstrate the short-term multiple-dose analgesic efficacy and safety of HTK-500 in subjects with pain from moderate lateral epicondylitis. The secondary objective of this study is to assess the onset of analgesic effect of HKT-500 in subjects with pain from moderate lateral epicondylitis.

• Male/Female 18 years of age and older.
• The subject has unilateral moderate epicondylitis of at least 2 weeks but less than 3 months duration at dosing (baseline). There should be a history of painless unrestricted motion of the affected joint immediately prior to the acute attack. If a subject had previously received treatment for the lateral epicondylitis with NSAIDs/Acetaminophen then the subject needs to have a history of epicondylitis improvement with NSAIDs / acetaminophen.

For more information,

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 5:44:55 AM